There was considerably significant difference in cancer immunity cycle (Fig. 7D), indicating a connection between the tumor immune microenvironment and the risk score, suggesting that TEX may influence the prognosis of HNSCC by modulating the immune cycle state. This evidence concerns the gene TEX46 and cancer.